Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Rubika Balendra1,2, Thomas G Moens1,2, Adrian M Isaacs1
1Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
EMBO Molecular Medicine
|May 24, 2017
Abstract
No abstract available in PubMed .
More Related Videos
08:53Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
9.2K
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
7.8K
